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Indirubin is a deep-red bis-indole isomer of indigo blue, both of which are 
biologically active ingredients in Danggui Longhui Wan, an ancient Chinese herbal tea 
mixture used to treat neoplasia and chronic inflammation, and to enhance 
detoxification of xenobiotics.  Multiple indirubin derivatives have been synthesized and 
shown to inhibit cyclin-dependent kinases (CDKs) and glycogen-synthase kinase (GSK-
3β) with varying degrees of potency.  Several indirubins are also aryl hydrocarbon 
receptor (AhR) agonists, with AhR-associated activities covering a wide range of 
potencies, depending on structure-activity-relationships (SAR).  In this study, the effects 
on indirubin-3’-(2,3 dihydroxypropyl)-oximether (E804), a novel indirubin derivative with 
potent effects on STAT3 signaling, on LPS-stimulated inflammatory profiles in RAW264.7 
murine macrophages were examined.  Most genes, proteins, and biological functions 
up-regulated by LPS treatment were suppressed by E804, including LPS-induced 
expression and secretion of pro-inflammatory cytokines.  Additionally, E804 enhanced 
HO-1 expression, which may promote antioxidant responses to control inflammation.  
However, RAW264.7 cells showed only modest CYP1A1 induction following treatment, 
thus at this time it is not clear if E804 modulates inflammatory responses in RAW264.7 
cells through AhR signaling.  To further explore the possible effects of E804 on AhR 
signaling, THP-1 human monocytes were differentiated to macrophages by a 48 hr 
treatment with phorbol-12-myristate-13-acetate (PMA), then treated with E804 and 
select other indirubin derivatives, as well as PCB-126 - a well-characterized AhR ligand 
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and potent inducer of CYP1A1.  CYP1A1 gene and protein expression were significantly 
induced by 7-bromoindirubin-3'-oxime (7BIO), another novel indirubin, and PCB-126, 
but not E804.  Furthermore, both 7BIO and E804 suppressed IL-6 and IL-10 secretion, 
thus confirming that AhR signaling is not a requirement for the anti-inflammatory 
properties of this compound.  Of particular note, 7BIO is a potent inducer of COX-2, 
another potent pro-inflammatory mediator known to be activated through the AhR.  
Taken together, this study demonstrates potent anti-inflammatory properties of E804 
without the toxicities historically associated with AhR activity. These findings can be 
applied to development anti-inflammatory drugs that may replace current methods for 
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Many plants have been used in Chinese medicine for over four millennia. One 
particular remedy, Danggui Longhui Wan, a mixture of eleven herbal medicines, has 
been used as a treatment of chronic myelocytic leukemia, as well as an antipyretic, anti 
inflammatory, and for detoxification (Zhu 1998). In 1966, Chinese researchers identified 
the active herbal component as Qing Dai (Indigo Naturalis), made from the leaves of 
Baphicacanthus cusia, Polygonum tinctorium, or Isatis indigotica (Wu, et al. 1979). The 
active compound was found to be indirubin, a dark-blue 3, 2’ isomer of indigo. Indirubin, 
together with indigo, are indigoids, both derived from a chemical family of bis-indoles. 
Indirubin is derived from the spontaneous, non-enzymatic dimerization of instain and 
indoxyl. These precursors are found in many natural sources, such as mollusks 
(Muricidae and Thaididae) (Cooksey 2001), bacteria (Gillam, et al. 2000), indigo-
producing plants (Maugard, et al. 2001), and in mammalian urine (Adachi, et al. 2001).  
Indigo has been used as dye since the Bronze Age to produce the dark blue pigment 
indigo. Natural indigoids can be obtained from the fermentation of indigo producing 
plants, from which indirubin is produced as a by-product.  
 
Anti-proliferative effects of indirubin 
Indirubin exerts its anti-proliferative effects by inducing cell cycle arrest in the 
G1/S or G2/M phases, resulting in inhibition of cell proliferation, and ultimately, 
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induction of apoptosis (Hoessel, et al. 1999, Marko, et al. 2001). Indirubin and many of 
its derivatives act as potent inhibitors of a variety of cyclin dependent kinases (CDKs) 
and glycogen synthase kinase-3β (GSK-3β), thereby preventing cell cycle progression 
(Hoessel, et al. 1999, Leclerc, et al. 2001, Marko, et al. 2001, Meijer, et al. 2003). They 
also affect apoptosis signaling and cell cycling via the wnt-signaling pathway (Meijer, et 
al. 2003). Indirubins inhibit cyclin-dependent kinase (CDK)1/cyclin B, CDK2/cyclin A, 
CDK2/cyclin E, CDK5/p25 and glycogen synthase kinase 3β (GSK-3β), one of the 
evolutionarily closest enzymes to the CDK family (Hoessel, et al. 1999, Leclerc, et al. 
2001, Lovestone, et al. 1996, Marko, et al. 2001). In addition, indirubin-3′-monoxime has 
been shown to inhibit c-Jun NH2-terminal kinase, an important regulator of neuronal 
apoptosis (JNK1, and JNK3) in vitro (Xie, et al. 2004).  
 
Kinase binding activity 
Indirubins exhibit a wide range of inhibition activities (IC50: 50 nM—100 µM) for 
both cyclin-dependent kinases and glycogen synthase kinase-3β (Hoessel, et al. 1999, 
Leclerc, et al. 2001, Polychronopoulos, et al. 2004). They have a high affinity for the 
enzyme ATP binding site and compete with ATP for the catalytic subunit of the enzyme 
(Eisenbrand, et al. 2004). A structure-activity relationship study suggests that indirubins 
bind to GSK-3β's ATP binding pocket in a way similar to their binding to CDKs (Leclerc, et 
al. 2001). Indirubins form three hydrogen bonds formed in the ATP-binding pocket with 
their NH, CO, and N’H groups, which are essential for binding to the peptide backbone 
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(Davies, et al. 2001, Hoessel, et al. 1999). Modifications at this region of the molecule 
cause indirubin to lose its affinity for the ATP binding pocket inhibition of CDKs. 
However, modifications at the 5’ and 3’ positions can be made to modify inhibitory 
potency, while methylation at N1 position renders indirubins kinase-inactive (Davies, et 
al. 2001, Knockaert, et al. 2004). 
 
AhR-binding  
Indirubin is also an agonist of the aryl hydrocarbon receptor (AhR), also called 
the dioxin receptor, a member of the bHLH/PAS family of transcriptional regulators 
found in most cell and tissue types of the body (Denison and Nagy 2003). The AhR 
mediates the effects of many xenobiotics such as 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD), polyaromatic hydrocarbons and polychlorinated biphenyls and indole-
containing compounds (Gonzalez and Fernandez-Salguero 1998, Hankinson 1995, Okey, 
et al. 1994). Xenobiotic ligand binding to the AhR triggers its translocation from the 
cytoplasm to the nucleus, where it forms a complex with the aryl hydrocarbon nuclear 
translocater (Arnt) (Hoffman, et al. 1991). The resulting heterodimer binds to xenobiotic 
response element (XRE) sequences upstream of cytochrome P450s, p27kip1, and other 
AhR-responsive genes, inducing their transcription (Kolluri, et al. 1999, Rowlands and 
Gustafsson 1997, Santini, et al. 2001). While structural modifications at certain positions 
can cause indirubins to lose affinity for the kinase ATP-binding pocket, these modified 
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indirubins are still potent AhR agonists, and no kinase-inhibiting indirubins have been 
found to be inactive on the AhR (Knockaert, et al. 2004).  
 
Dual mechanisms of cell-cycle inhibition 
While indirubin inhibits the cell cycle though the direct inhibition of cyclin 
dependent kinases, indirubin may also control the cell cycle though kinase-independent 
inhibition of cycling (Adachi, et al. 2004, Knockaert, et al. 2004). The AhR was implicated 
in cell cycle arrest at G1 through the down-regulation of cyclins and cyclin-dependent 
kinases, as well as by induction of cyclin-dependent kinase inhibitors such as 
p21(CDKN1A) and p27Kip1 (CDKN1B ) (Adachi, et al. 2001, Cover, et al. 1999, Kawanishi, 
et al. 2003, Knockaert, et al. 2004, Ma and Whitlock 1996). The kinase-inactive 1-
methyl-indirubins, cause an AhR-dependent cell cycle arrest in G1, that appears to be 
directly linked to the AhR-dependent expression of p27KIP1 (Knockaert, et al. 2004). 
While direct kinase inhibition seems to represent the main mechanism of cytotoxicity, 
AhR activation is responsible for the cytostatic effects induced by some indirubins. 
 
AhR activity 
As with kinase inhibitory activities, the AhR activities of different indirubin 
derivatives cover a wide range of potency, with EC50 values between 5 nM – to over 10 
µM for CYP1A1 enzymatic activity in hepatoma cells and 6 nM – to over 100 µM in a 
yeast reporter assay system (Knockaert, et al. 2004).  In comparison to indirubin with an 
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EC50 of 6 nM for both assays, TCDD-induced CYP1A1 activity was 15 pM in the hepatoma 
cell line and 25 nM in a yeast reporter assay, but it has been shown that yeast reporter 
systems underestimate the potency of TCDD (Knockaert, et al. 2004, Miller 1999).  There 
also appears to be a species-specific effect as indirubin had a 35-140 times higher 
EC50 value in yeast with human genes than mouse genes (Kawanishi, et al. 2003). While 
good screening tools, reporter systems have limited use, therefore, they can be poor 
substitutes for quantitatively accessing AhR potency.  
The discovery of the interaction of indirubin with AhR has raised questions about 
its potential use since AhR activation has been directly linked to carcinogenesis, immune 
suppression, as well as reproductive and developmental disorders (Kaminski, et al. 2008, 
Safe 2001, Shimizu, et al. 2000). Gene expression studies have shown similar patterns of 
expression between indirubin and TCDD, though indirubin appears to be more potent. 
The lowest observed effective concentration (LOEC) for CYP1A1 and CYP1A2 mRNA 
induction in human cells was 100 pM for TCDD but only 1 pM for indirubin, the lowest of 
any AhR ligand (Adachi, et al. 2004). However, indirubin induced CYP1A1 and 1B1 
expression only transiently in human breast cancer cells and the potency of indirubin 
increased when cells were treated with the CYP inhibitor (Spink, et al. 2003). While the 
binding affinity of the PAH benzo[a]pyrene was similar to that of indirubin, the long-
term induction of cyp1a1 expression seen with B[a]P was not observed with indirubin 
(Adachi, et al. 2004). Together these studies suggest that while indirubin is a potent AhR 
ligand, the negative long-term effects of AhR activation commonly associated with toxic 
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environmental ligands may not be seen with indirubin. Strong AhR agonists like TCDD, 
which bind AhR with high affinity and are recalcitrant to metabolism, may have far 
lasting toxic effects on cell cycling and whole organ/organism toxicities than would 
indirubins, which are much more quickly metabolized by the P450s induced as a 
consequence of AhR-activation.  Lacking the stability of highly toxic AhR ligands make 
indirubins an attractive alternative as potential therapeutic agents.  
 
Indirubin derivative E804 
One particular indirubin derivative, indirubin-3’-(2,3 dihydroxypropyl)-oximether 
(E804), has been shown to directly and potently inhibit c-Src kinase activity (IC50:0.43 
µM) in vitro, thus blocking downstream Stat3 and Stat5 signaling (Nam, et al. 2005, 
Nam, et al. 2012). Src kinase as an upstream regulator of Stat3 plays a key role in cell 
proliferation, tumorigenesis, and metastasis by phosphorylating cellular substrates that 
results in activation of oncogenic signal transduction pathways (Courtneidge and 
Fumagalli 1994, Parsons and Parsons 2004, Yeatman 2004). Stat3 is also a critical 
regulator of effector functions of the activated innate immune system, as it is the 
primary means by which IL-10 mediates its anti-inflammatory actions in peritoneal 
resident macrophages (Matsukawa, et al. 2005), as well as being a transcriptional 
mediator for the IL-6 family cytokines (Hirano, et al. 2000). E804 inhibits Src kinase with 
an IC50 of 0.43 µM, similar to IC50 values with which E804 inhibits CDK1/cyclin B, 
CDK2/cyclin A, and CDK1/cyclin E complexes (1.65, 0.54, and 0.21 μM, respectively), 
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causing G2/M cell cycle arrest (Nam, et al. 2005). It is thought that E804 competitively 
binds to the ATP-binding site of Src tyrosine kinase, similar to the mechanism by which 
indirubin inhibits CDKs (Nam, et al. 2005). To a lesser extent, E804 also inhibits Jak1 
kinase activity (Nam, et al. 2005), which works together with Src kinase to mediate 
constitutive activation of Stat3 (Campbell, et al. 1997, Garcia, et al. 2001).  Studies have 
suggested that E804 may block this cooperation of Src and Jak1 kinases involved in 
tyrosyl phosphorylation of Stat3 and Stat5 (Nam, et al. 2005, Nam, et al. 2012).  
Stat3 also physically interacts with NF-κB, suppressing constitutive and LPS-
induced NF-κB activation (Hoentjen, et al. 2005, Welte, et al. 2003, Yu and Kone 2004). 
NF-κβ is from a family of Rel domain-containing proteins activated by wide range of 
stimuli, including pathogens, carcinogens, stress signals and pro-inflammatory cytokines 
(Li and Verma 2002). NF-κβ is kept in the cytoplasm bound to inhibitors of NF-κβ (Iκβ). 
Upon activation, Iκβ proteins are phosphorylated by Iκβα kinase (IKK), ubiquitinated and 
degraded. NF-κβ is translocated to the nucleus, where it regulates genes involved in 
antiapoptosis, cell cycle regulation, and inflammation.   
Conversely, indirubin has been shown to directly suppress NF-κβ activation 
through inhibition of IKK, leading to suppression of Iκβα phosphorylation and 
degradation (Sethi, et al. 2006). The suppression of NF-κβ by indirubin leads to down-
regulation of gene products involved in cell proliferation, anti-apoptosis, and immune 
responses. In microglial cells, indirubin-3′-oxime reduced LPS-elicited NF-κβ activation, 
inhibiting nitric oxide release and reducing production of pro-inflammatory cytokines 
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(Jung, et al. 2011). Another study in microglial cells showed that indirubin-3′-oxime was 
effective at suppressing the expression of iNOS, IL-6, but not COX-2 (Yuskaitis and Jope 
2009). Indirubin-3’-monoxime significantly inhibited COX-2 activity in a variety of cells, 
preferentially affecting COX-2-catalyzed prostaglandin synthesis (Danz, et al. 2001, Jung, 
et al. 2011, Sethi, et al. 2006). However, one study using the same indirubin derivative 
showed increased COX-2 in activated macrophages (Springs and Rice 2006). 
 
Role of indirubins in mediating inflammation 
Inflammation occurs in response to tissue damage, pathogens, or pathogen 
products and is mediated by a variety of immunocompent cells. Macrophages are 
important in innate immunity as phagocytes, in production of inflammatory cytokines, 
and in initiating the adaptive response through presentation of antigens to effector T-
lymphocytes (Janeway, et al. 2001, Laskin and Pendino 1995). Macrophages are 
activated when their pattern recognition receptors (PRRs) recognize pathogen-
associated molecular patterns (PAMPS), such as toll-like receptors (TLRs) binding 
lipopolysaccharide (LPS) from the gram-negative cell wall (Gordon 2002, Imler and 
Hoffmann 2000). Activation of TLR4 signaling pathways by bacterial endotoxin 
lipopolysaccharide (LPS) leads to NF-κβ signaling as the primary transcription factor 
driving the expression of iNOS, IL-6, and COX-2 and various other genes involved in 
inflammatory responses in macrophages (Tak and Firestein 2001, Yu and Kone 2004). 
Macrophages treated with LPS also produce the anti-inflammatory cytokine IL-10 to 
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limit their response, which is mediated through TLR4/MAPKinases and Sp-1-dependent 
signaling (Chanteux, et al. 2007). 
While acute inflammation is critical for pathogen clearance, inflammation 
resulting from chronically activated macrophages is associated with multiple diseases 
including autoimmunity, cardiovascular disease, and tumor promotion and growth 
(Coussens and Werb 2002, Doria, et al. 2012, Libby, et al. 2002). Therefore, safe and 
effective interventions are needed to modulate macrophage functions during chronic 
inflammatory states. Lacking the stability of highly toxic AhR ligands make indirubins an 
attractive alternative as potential therapeutic agents. This study seeks to examine the 
effects of indirubin-3’-(2,3 dihydroxypropyl)-oximether (E804) and 7-bromoindirubin-3'-
oxime (7BIO) on inflammatory profiles, including gene and protein expression, cytokine 
production, and functional endpoints, using bacterial endotoxin lipopolysaccharide (LPS) 
as stimulation towards a highly pro-inflammatory state.  The studies described herein 
are the first to determine the potential anti-inflammatory properties of novel indirubin 
derivatives using mammalian macrophage cell lines, and to determine if being an active 
AhR ligand is necessary for anti-inflammatory properties.  Much of the previously 
published literature on natural indirubin and its derivatives has been focused on anti-
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Indirubin is a deep-red bis-indole isomer of indigo blue, two biologically active 
ingredients in Danggui Longhui Wan, an ancient Chinese herbal tea used to treat 
neoplasia , chronic inflammation, and to enhance detoxification and detoxication of 
xenobiotics (Wu et al., 1979; Hoessel et al., 1999; Leclerc et al., 2001).  Natural indirubin 
and its multiple synthetic derivatives inhibit cyclin-dependent kinases (CDKs) and 
glycogen synthase kinase-3β (GSK-3β), thereby preventing cell cycle progression 
(Hoessel et al., 1999; Leclerc et al., 2001; Marko et al., 2001; Meijer et al., 2003), and 
also affecting apoptosis signaling and cell cycling via the wnt-signaling pathway.   
 
  AhR binding 
Several indirubin derivatives are strong aryl hydrocarbon receptor (AhR) ligands 
(Adachi et al., 2001; Kawanishi et al., 2003; Adachi et al., 2004; Knockaert et al., 2004; 
Springs and Rice, 2006).  The AhR is a member of the basic helix-loop-helix (bHLH-PAS) 
superfamily of proteins and functions as a ligand-activated transcription factor  (Gu et 
al., 2000) for a suite of responsive genes.  Most notable of these genes in the fields of 
toxicology and pharmacology include phase I and II drug-metabolizing enzymes and 
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transporters (Nebert et al., 2000; Denison et al., 2002a; Hu et al., 2007b; Kohle and 
Bock, 2007). Adverse effects of exposure to persistent environmental AhR ligands 
include immune suppression, as well as reproductive and developmental disorders 
(Kaminski et al., 2008). 
 
CDK and AhR activities 
As with CDK and GSK-3β inhibitory activities, indirubin-related AhR activities 
cover a wide range of potency, with EC50 values between 5 nM – to over 10 µM for 
CYP1A1 enzymatic activity in hepatoma cells, and 6 nM – to over 100 µM in a yeast 
reporter assay system (Knockaert et al., 2004; Polychronopoulos et al., 2004).  In 
comparison, the EC50 for TCDD-induced CYP1A1 activity in the Knockaert et al study was 
15 pM in the hepatoma cell line and 25 nM in a yeast reporter assay.  Taken together, 
these observations indicate that strong AhR agonists like TCDD, which bind AhR with 
high affinity and are recalcitrant to metabolism, may have far lasting toxic effects on cell 
cycling and whole organ/organism toxicities than would bis-indole derivatives like 
indirubins, which are much more quickly metabolized by the P450s (Spink et al., 2003).  
Lacking the stability of highly toxic AhR ligands make indirubins an attractive alternative 
as potential therapeutic agents for adverse immune responses, including chronic 
inflammation. 
 
Indirubin as an anti-inflammatory 
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Inflammation is a physiological response to both tissue damage and breaching of 
physiological barriers by pathogens and their products, and involves a complex interplay 
between tissue-fixed macrophages, mast cells, and the recruitment of monocytes, 
granulocytes, and dendritic cells for wound and tissue repair.  Macrophages, in 
particular, play a significant role in coordinating the balance between wound repair and 
pathogen clearance, and do so through cytokines, growth factors, and reactive oxygen 
species (Mantovani, 2006; Dall’Asta et al., 2012).  Inflammation resulting from 
chronically activated macrophages is associated with multiple disease types including 
autoimmunity, cardiovascular disease, and tumor promotion and growth.  Therefore, 
safe and effective interventions are needed to modulate macrophage functions during 
chronic inflammatory states. 
Indirubin-3’-(2,3 dihydroxypropyl)-oximether (E804) is a recent indirubin 
derivative possessing novel activity against Stat3 signaling (Nam et al., 2005).  Stat3 
inhibition by E804 is also associated with impaired normal vascular development as well 
as reduction of tumor vasculature development (Chan et al., 2012; Shim and Kim, 2012).  
Stat3 signaling is significant in the context of inflammatory processes because signaling 
through Stat3 is the primary means by which IL-10 mediates its anti-inflammatory 
actions in peritoneal resident macrophages (Matsukawa et al., 2005). Furthermore, IFN-
γ induced MHC-II expression and antigen presentation in human blood 
monocyte/macrophages are suppressed by IL-10 through Stat3 signaling (Chan et al., 
2010).  The suppressive effects of at least one indirubin derivative, indirubin-3’-
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monoxime, on activated macrophages is suppressive for activated and differentiating 
human U937 monocytes (Springs and Rice, 2006), and for LPS-activated microglia (Jung 
et al., 2011).   
 
Role of macrophages in inflammation 
To date, no published studies have examined the effects of E804 on macrophage 
functional endpoints and pro-inflammatory responses to LPS.  Using RAW264.7 murine 
macrophages, the first study described herein tested the hypothesis that E804 is a 
potent modulator of key genes, proteins, and functions in macrophages exposed to LPS.  
We found that 1 µm E804 suppresses LPS-induced iNOS, COX-2, IL-6, and IL-10 
expression, which is associated with reduced phagocytosis, cellular lysozyme activity, 
and intracellular killing of bacteria without cytotoxicity, apoptosis, or necrosis. 
Despite the potent anti-inflammatory properties of E804 in RAW264.7 cells, this 
compound lacks significant AhR-associated CYP1A1 activity, at least in these cells, 
possibly indicating weak AhR-associated properties of this indirubin derivative, or that 
this particular cell line lacks necessary components of AhR signaling.  Based on this 
unanswered question, other macrophage cell lines were evaluated.  THP-1 cells are a 
human acute monocytic leukemia line (Tsuchiya et al., 1980) that can be differentiated 
along a monocyte-macrophage direction in response to PMA (Schwende et al., 1996).  
These cells are phagocytic, express lysozyme, and express cytokines, proteins, and 
markers typical of primary macrophages (Daigneault et al., 2010), and have been used in 
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immunopharmacology and toxicology (Ustyugova et al., 2007).  Moreover, as described 
in the methods section (this dissertation), PMA-differentiated cells THP-1 cells easily 
express CYP1A1 in response to a variety of AhR ligands, including PCB-126, and 
prototypic AhR ligand used in toxicological research. 
 
Role of neutrophils in inflammation 
One of the key events in inflammatory processes is the recruitment of 
neutrophils into extravascular tissues in response to both pathogens and tissue debris 
(Futosi et al., 2013).  Sentinel macrophages, upon activation by pathogen-associated 
molecular patterns (PAMPs), and damage-associated molecular patterns (DAMPs), 
including various TLRs, innately secrete IL-1β, TNF-α, IL-6, IL-8, and GM-CSF.  IL-8 is a 
chemokine principally directed towards neutrophils to extravagate between capillary 
endothelial cells (diapedesis), and migrate towards the source of IL-8 (Tsirogianni et al., 
2006).  GM-CSF initiates increased granulocyte and monocyte hematopoiesis to further 
a source of monocytes and neutrophils towards the site of inflammation and tissue 
damage (Egea et al., 2010).  This wave of neutrophil influx towards local inflammatory 
events allows for rapid phagocytosis, intracellular and extracellular killing of pathogens 
through oxygen-independent and oxygen-dependent mechanisms, respectively 
(Edwards et al., 1987; Rigby and DeLeo, 2012).  In the face of high levels of TNF-α at the 
site of inflammation, neutrophils can be “primed” (El-Benna et al., 2008) for a 
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heightened state of phagocytosis and oxidative burst to produce superoxide anion and 
other reactive oxygen intermediates (Babior, 1999; Babior et al., 2002; Cathcart, 2004). 
The phagocyte oxidative burst is produced by the membrane associated NADPH 
oxidase system, a complex of dissociated units located in the membrane and cytosol in 
the resting state, but rapidly assembled upon activation (Babior, 1999).  Units p40PHOX, 
p47PHOX, p67PHOX, and Rac2 reside in the cytosol, while Rap1A and cytochrome b558, 
and a p22PHOX/gp91PHOX unit reside in the membrane.  Upon activation, p47PHOX is 
phosphorylated and cytosolic units migrate to the membrane and complex with 
cytochrome b558, thereby assembling the oxidase system.  Increases in intracellular 
Ca++ may lead to activation of phospholipase A2 activity, followed by arachidonate 
release Protein kinase C (PKCα) which can regulate the translocation of p47PHOX.  
Phagocytosis events can lead to activation of phospholipase C, and subsequent release 
of DAG and IP3, thus activating PKCδ and releasing Ca++ from the endoplasmic 
reticulum, respectively.  PKCδ rapidly phosphorylates p67PHOX and p47PHOX, and 
assembles the NADPH oxidase system.  NADPH oxidase converts molecular oxygen to 
superoxide anion – the major anti-microbial oxygen radical.  Under experimental 
conditions, phorbol mysristate acetate (PMA), a molecular mimic of DAG, can rapidly 
induce the NADPH oxidase system to produce superoxide anion.  Furthermore, calcium 
inophores (A23187, ionomycin) can increase intracellular calcium.  Under most 
circumstances, both PKCα and PKCδ are involved (Cathcart, 2004). 
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Considering the importance of neutrophil/monocyte/phagocyte oxidative burst 
in inflammatory processes, it may be a molecular target for a variety of pharmacological 
and toxicological agents.  Oxidative burst activities are routinely evaluated as an 
endpoint in monitoring phagocyte integrity in virtually all multi-cellular organisms, from 
plants (Torres and Dangl, 2005), to invertebrates (Park et al., 2012; Di et al., 2013), fish 
(Rice and Weeks, 1991; Kelly-Reay and Weeks-Perkins, 1994; Palić et al., 2006), 
amphibians (Graham et al., 2012), birds (Kogut et al., 2001), and to all species of 
mammals (Keogh et al., 2011).  Because of their short life span, typically only a few days 
post-migration from hematopoiesis (Simon and Kim, 2010), there are no suitable and 
functional mature neutrophil cell lines.  However, HL-60 human promyelocytic leukemia 
cells (Gallagher et al., 1979) can be differentiated to neutrophils over a 6 day period 
with retinoic acid (Breitman et al., 1980; Hauert et al., 2002).  HL-60 derived neutrophils 
are phagocytic and have the full array of assembled NADPH oxidase system when 
activated (Nordenfelt et al., 2009). 
In this study, retinoic acid-differentiated HL-60 cells were used as a model for 
understanding the possible effects of indirubins on neutrophil oxidative burst.  This 
model was used under two conditions; as un-primed cells lacking exposure to 
supernatants containing pro-inflammatory cytokines, and as primed cells following a 24 
hr exposure to supernatants from the human mast cell line HMC-1 (Butterfield et al., 
1988; Nilsson et al., 1994), a generous gift to the lab from Dr. Joseph H. Butterfield, 
Mayo Clinic, Rochester, MN,  and known to produce large amounts of TNF-α and IL-6 
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(Chi et al., 2004; Sohn et al., 2013).  In this model, PMA is used to stimulate the 
oxidative burst in the presence of H2DCFA, a common fluorescing probe for reactive 
oxygen intermediates produced during burst activity (Possel et al., 1997; Eruslanov and 
Kusmartsev, 2010). 
 
Role of E804 in mediating inflammation 
Taken together, and by using three different cell lines, RAW264.7, THP-1, and HL-
60 cells, it was found that E804 is a very weak AhR agonist, but very potent in 
suppressing LPS-inducible pro-inflammatory genes and proteins in macrophages.  On 
the other hand, 7-bromoindirubin-3’-monoxime (7BIO) is a very potent AhR agonist, and 
is not as strong as E804 in reducing LPS-stimulated events in macrophages.  Neither of 
these two indirubins significantly modulates the oxidative burst activity of neutrophils.  
The thesis of this dissertation is that E804 is an excellent candidate for developing anti-
inflammatory preparations (creams, tablets etc.) for use in clinical medicine, while 




MATERIALS AND METHODS 
I.  RAW264.7 cells 
 
Cells and cell culturing 
 
 The murine macrophage cell line RAW 264.7 was obtained from ATCC 
(Manassas, VA USA) and maintained in Dulbecco’s modified Eagle’s medium (DMEM; 
CellGro Mediatech) supplemented with 10% heat-inactivated fetal calf serum (FCS) with 
iron (Atlas; Fort Collins CO USA), 20 mM HEPES, 10 mM  L-glutamine, 100 U/mL 
penicillin, 100 µg/ml streptomycin, 110 µg/ml sodium pyruvate, 1% non-essential amino 
acids (100 X stock), 4.5 g/L glucose, and 1.5 g/L of NaHCO3, each from Sigma (Sigma 
Aldrich).  Cells were typically grown and maintained at 37°C with 5% CO2 in Corning 75 
cm2 culture flasks. 
 
Cytotoxicity assays 
   
Indirubin-3’-(2,3 dihydroxypropyl)-oximether (E804; Alexis Biochemical) was solubilized 
in DMSO (Sigma Aldrich) to a stock solution of 10-2 M and stored at -20° C in sealed vials 
until ready for use.  Stock preparations were diluted to a final working concentration 
using supplemented DMEM just prior to use.  The chemical structures for natural 
indirubin and E804 are shown in Figure 1.  Unless otherwise noted, cells were treated 
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with 0.01% DMSO carrier, 1 µM E804 alone, 1 µg/ml LPS from E. coli, Serotype 0127:B8 











Molecular structures of (A) natural indirubin and (B) indirubin-3’-(2,3 dihydroxypropyl)-
oximether (E804) used or referenced within the study.
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Cellular respiration as an indication of viability was measured by the MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay.  Macrophages were 
plated into 96 well Costar plates at 105 cells per well in 100 μl of DMEM media.  After 4 h 
of incubation at 37°C for adherence, compounds and DMSO carrier control (0.01% final) 
were added in triplicate over serial dilutions beginning with 50 µM per well in a total 
volume of 200 µl, and the plates incubated for 24 h.  Four hours before termination of 
the assay, each well received 20 μl of a 5 mg/mL MTT solution in DMEM.  After 
centrifugation, the supernatant for each well was discarded and cells containing 
reduced MTT were solubilized with 100 μl of acidified isopropanol (4 mM HCl, 0.1% NP-
40 in isopropanol).  Following a brief period of shaking the optical density (O.D.) for each 
well was recorded at 550 nm.  Each experiment was repeated three times and the data 
averaged from each triplicate, then expressed as percentage of the control O.D. values 
for each experiment.  For statistical purposes, percentage data were arcsine 
transformed and compared by ANOVA and Bonferroni’s multiple contrast post-hoc tests 
using Graphpad5.  Prior to experiments, an α value of 0.05 was established as 
statistically significant for cytotoxicity determinants and throughout this study. 
 
Annexin V labeling assays 
 
Results from MTT assays indicated that 1 µM and less of E804 were not 
cytotoxic, yet MTT assays quantify only cellular respiration-related viability and not 
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necessarily ongoing cell death due to apoptosis or necrosis.  Potential apoptosis 
following exposure to 1 µM E804 was subsequently evaluated using an ApoScreen™ 
Annexin V Apoptosis Kit (Southern Biotech).  Since the study herein would also involve 
LPS treatments in combination with E804, the potential interactions between 
compound and LPS in terms of possible apoptotic effects were also evaluated.  Briefly, 
macrophages were seeded at 1.5 x 106 cell/well in 6 well plates over 4 h for adherence, 
and treated with 0.01% DMSO carrier, 1 μg/ml LPS, 1 μM E804, or both in combination 
for 24 h.  Cells were then washed x 3 with ice-cold PBS and 500 μl of Annexin V binding 
buffer.  Binding buffer was added to all wells, along with Annexin V-FITC, and the 
mixture incubated for 15 min on ice in the dark.  Without washing, 380 μL of cold 
binding buffer and propidium were added to each well.  After extensive wash steps, cells 
were gently scraped from attachment and aliquots processed by flow cytometry using 
FACScan™ (BD Biosciences), with 10,000 cells being scored in each run. 
 
Commercial qRT-PCR arrays for stress and toxicity 
 
Macrophages were seeded at 1.5 x 106 cells/ml in 75 cm2 Corning culture flasks 
and allowed to adhere for 4 h. Cells were then treated for 24 h with 0.01% DMSO 
carrier, 1 μM of E804, 1 ug/ml LPS alone, or both in combination.  This experimental 
regimen was repeated three times and the adhered macrophages scraped from the flask 
surfaces and pooled (n = 3) per treatment regimen, then harvested by centrifugation to 
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have one pooled pellet from each of the 3 replicated experiments.  TRI-reagent® was 
added (1 ml) to cell pellets and the mixture homogenized by gentle pipetting several 
times. The homogenate was incubated at room temperature for 5 min and 0.2 ml 
chloroform added. After incubating the mixture for 15 min, samples were centrifuged at 
12,000 x g for 15 min at 4°C. The aqueous phase was transferred to a new 1.5 ml micro 
centrifuge tube and the total RNA precipitated with 0.5 ml isopropyl 
alcohol/isopropanol over a 10 min period, then centrifuged again at 12,000 x g for 15 
min, and re-dissolved in DEPC-treated water. 
After collecting RNA from each tube, genomic DNA contamination was removed 
using elimination mixture supplied by the manufacturer, and first strand cDNA synthesis 
was carried out using the RT2 Easy First Strand Kit (SABioscience Corporation) as 
described by the manufacturer.  A predesigned Stress & Toxicity Profiler™ array of 96 
genes was purchased from SuperArray Bioscience Corporation for use with RT2 Real-
Timer SYBR Green/fluorescein qPCR master mixes purchased from the same supplier.  
Specific methods followed those suggested by the manufacturer.  RT-qPCR was 
performed on a BioRad iQ5 real-time PCR detection system.  For data analysis, the ΔΔCt 
method was used; for each gene fold-changes were calculated as difference in gene 
expression between untreated controls and treated cell cultures.  Data were gathered 
and interpreted using software provided by SABioscience.  The manufacturer suggests a 
two-fold change in gene expression to be of significance, but statistical significance was 
not determined from a single pooled sample – our goal from the pooled sample was to 
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determine which genes may be of interest to follow up with, confirm using regular qRT-




The above treatment regimen was repeated, but samples from the three 
replicated experiments were examined individually and not pooled.  RNA was extracted 
and cDNA obtained from treated murine macrophages as described above, but for both 
12 and 24 h.  Gene expression was analyzed by quantitative real-time PCR with a BioRad 
iC5 detection system, RT² SYBR green/ fluorescein master mix, and primer sets designed 
using Integrated DNA Technology (IDT) software, and validated prior to use (Table 1). 
The quantity of these mRNAs was expressed as fold-changes in gene expression 
compared to β-actin expression.  For data analysis, the ΔΔCt method was used.  
Expression data were compared between treatment groups using ANOVA, followed by a 




Gene Name Accession #  Primer Sequence (5’    3’)                Tm 
0
C        Product  
                                    size (bp) 
 
GAPDH  NM_008084  F: TGT GAT GGG TGT GAA CCA CGA GAA 57 115 
     R: ACC CTG TTG CTG TAG CCG TAT TCA 
 
IL-6  NC_000071.5  F: TTG TAC AGT CCC AGT CAG GCA ACA  58 80 
     R: TCA AGC TAC TGC AGG CCA GTT ACA 
 
COX-2  NC_000067.5  F: GCC AGC AAA GCC TAG AGC AAC AAA 57.2 144 
     R: TAC TGA GTA CCA GGC CAG CAC AAA 
 
iNOS  NM_010927  F: CAA ACA CGA GTG CAG CTG GTT GAA 58 115 
     R: AGG CAG GAC TGA GTT CAG TGT GTT 
 
IL-10    NM_010548.2  F: ACTGCTATGCTGCCTGCTCTTACT  57 90 
     R: ACTGGGAAGTGGGTGCAGTTATTG   
  
CYP1A1  NM_009992  F: TAT GAC ACA GAG CAA CAG CAG GGT 57 154 




qRT-PCR primer sequences targeting murine IL-6, COX-2, iNOS, IL-10 and CYP1A1.
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Immunoblotting for iNOS and COX-2 protein expression 
 
 Triplicate experiments were performed in which 1.5 x 106 macrophages were 
seeded in T-25 flasks in 3 ml of media containing 0.01% DMSO carrier control, 1 µM 
E804, 1 µg/ml LPS, or both compounds,  and incubated for 12 and 24 h.  Cells were 
scraped from each flask and pelleted by centrifugation and covered with 500 µl RIPA 
lysis buffer (50 mM Tris HCl, pH 8, 150 mM NaCl, 1 % NP-40, 0.5% sodium deoxycholate, 
and 0.1% SDS) containing protease inhibitor cocktail (Pierce).  The cell pellet was 
disrupted by gentle vortexing, and incubated on ice for 30 min, then centrifuged at 1000 
x g for 10 min.  The overlying supernatant was removed and centrifuged again for 20 
min at 14,000 x g; the overlying supernatant was again removed and its protein content 
quantified.  Fifty µg of lysate protein from each sample were separated by SDS-PAGE on 
10% gels and transferred overnight onto 0.45 µM nitrocellulose membranes at 40 C.  The 
membranes were washed three times with 0.01 M phosphate buffered saline (PBS) 
containing 0.1% tween-20 (PBS-tw20), covered with blocking buffer (10% FCS in PBS) for 
1 h and again washed three times with PBS-tw20.  Membranes were then probed for 2 h 
with goat anti-COX-2 antibody (C-20; Santa Cruz Biotechnology) at 1:750, rabbit anti-
mouse iNOS (#610333; BD Transduction Labs) at 1:500, or anti-mouse β-actin (mAb AC-
74; Sigma Chemical Company) at 2 µg per ml.  Antibodies were diluted in PBS-tw20 
containing 1% FCS.  The blots were washed three times for 10 min with PBS-tw20, and 
probed for 2 h with either rabbit anti-goat IgGm goat anti-rabbit IgG, or goat anti-mouse 
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IgG secondary antibody conjugated with alkaline phosphatase (SouthernBiotech) diluted 
1:1000 in PBS-tw20 containing 1% FCS.  After extensive washings with PBS-tw20, 
alkaline phosphatase activity was determined using the substrate NBT-BCIP as means to 
visualize the relative amount of specific protein.  Band densities for each protein were 
quantified using BioRad G-17  documentation system, and the relative amount of iNOS 
and COX-2 protein expression were normalized to the β-actin loading control.  Data 
were expressed as relative expression compared to β-actin. 
 
IL-6 and IL-10 secretion, iNOS and lysozyme enzymatic activity 
 
For IL-6 and IL-10 secretion, and iNOS activity assessment, cells were seeded in 
96 well plates at 105 cells per well in supplemented MEM-alpha lacking phenol red 
(#41061-029, Gibco).  Following a 4 h incubation period for adherence, cells were 
treated for 24 h with 0.01% DMSO carrier control, 1 µM E804, 1 µg/ml LPS, or both in a 
final volume of 200 µl.  Interleukin-6 was quantified by mouse READY-SET-GO IL-6 ELISA 
systems (eBioscience) following the directions provided by the supplier.  Interleukin-10 
was quantified by mouse IL-10 ELISA MAX systems (Biolegend).  Briefly, 100 μl of 
supernatant were removed from each well 24 h after initiation of treatments and added 
to a pre-coated capture antibody Costar maxi-sorb plate provided by the kits, and 
incubated overnight at 4°C.  The plates were washed and blocked using reagents 
provided by the vendor.  Detection antibody was added for 1 h, followed by treatment 
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with avidin-HRP and a colorimetric substrate solution.  A phosphoric acid stop solution 
was added, and the plate read at 450 nm.  Concentrations of cytokines were plotted 
against the standard curve of known concentrations supplied by the manufacturer.   
To quantify iNOS activity as NO secretion, 100 μl aliquots of supernatants were 
incubated in 96 well plates at room temperature for 15 min with an equal volume of 
Griess reagent (equal parts reagent 1; N-(1-naphthyl)-ethylenediamine dihydrochloride, 
and reagent 2; Sulfanilamide).  The O.D. was measured at 550 nm and compared to a 
NaNO2 standard curve.  Values per replicate wells and per treatment replicates were 
averaged and then plotted.  Cytokine and NO data were compared using ANOVA 
followed by a Bonferroni’s post- test using GraphPad5 statistical package. 
The enzymatic activity of lysozyme was measured in RAW 264.7 cells based on 
modifications of published procedures (Parry et al., 1965; Burton et al., 2002).  Cells 
were seeded into 6 well plates at 1.5 x 106 per well in DMEM complete media and 
allowed to adhere for 4 h prior to treatment, then incubated for 24 h.  Cells were lysed 
and the protein concentration normalized to 1 mg/ml.  One hundred µl of cell lysate, in 
triplicate, were added onto 96 well plates followed by the addition of 200 µl of 2 mg/ml 
heat killed Micrococcus lysodietikus (Sigma Aldrich) in 0.01 M PBS, pH 4.0.  The 
enzymatic reaction was carried out in an uGuant microplate reader at room 
temperature. The plates were read at wavelength 450 nm every 5 min for 30 min, then 
again at 10 min intervals for an additional 30 min. One unit of lysozyme activity was 
defined as a decrease in absorbance of 0.001 min-1.  Enzymatic activity data were 
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compared between treatment groups using ANOVA, followed by a Bonferroni’s post- 




Phagocytic capability of RAW264.7 cells following 24 h treatment was 
determined by their ability to phagocytize 1 µM fluorebrite carboxylate YG 
microspheres (Polyscience) using modifications of previously described methods 
(Bozzaro et al., 1987; Peracino et al., 1998).  Washed beads, diluted in 50 mM Na2HP04, 
were added to 105 treated cells in flat- bottom 96 well plates at a ratio of 100:1 (beads: 
cells) in a total of 200 µl media.  Each treatment involved 12 wells of the plate, and the 
experiment was repeated three times.  After adding beads to cells, the plates were 
centrifuged lightly for 5 min to maximize contact between cells and beads, and plates 
incubated at 37°C for 45min.  Extracellular microspheres were then removed by 3 
washes with PBS in a series of centrifugation steps (500 rpm for 5 min).  Phagocytosis 
was stopped by the addition of 100 μl ice cold PBS with 1 mM CaCl2 and MgCl2.  Trypan 
blue (2 mg/ml) dissolved in 20 mM citrate and 150mM NaCl, pH 4.5, was added to 
quench any fluorescence from adhered, but not internalized beads.  Plates were then 
read on a FLx-800 fluorescent spectrophotometer at an excitation wavelength of 485 
nm and emission wavelength 528 nm.  Data from the 12 wells were gathered as 
fluorescence units, averaged for each experimental replicate, and compared to the 
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control as percentages and arcsine transformed prior to statistical analysis.  Data were 
compared between treatment groups using ANOVA, followed by a Bonferroni’s post- 
test using GraphPad5 statistical package. 
 
Intracellular killing assays 
 
The effects of treatment on intracellular killing of E.coli was measured based 
previously published methods (Boleza et al., 2001).  Briefly, RAW 264.7 cells were 
seeded onto 96 well plates at a concentration of 105 cells per well, allowed to adhere for 
4 h, and treated in a total volume of 200 ul for 24 h.  Each treatment utilized 12 wells of 
the plate.  E.coli were then added at a ratio of 25:1 (bacteria:cells) and incubated for 
180 min at 37°C.  Extracellular bacteria were removed by extensive washing with PBS, 
and further treated with 200 μl of 1000 U Penicillin and 10 µg/mL streptomycin solution 
(Sigma Aldrich) for 15 min.  Cells were then permeablized with 100 µl 0.1% triton-x100 
in PBS for 15 minutes to release the engulfed bacteria.  The Triton X-100 solution was 
removed by aspiration and the viable bacteria in each well were grown in 200 µl LB 
broth for 12 hours.  Live bacteria were determined using the MTT assay, and results 
presented as a percentage of control treated cells.  Percentage data were arcsine 
transformed prior to statistical analysis using ANOVA, followed by a Bonferroni’s post- 




II.  THP-1 Cells 
 
The human monocytic cell line THP-1 was obtained from ATCC (Manassas, VA 
USA) and maintained in RPMI-1640 (Cellgro) supplemented with 10% heat-inactivated 
FCS with iron (Atlas; Fort Collins CO), 20 mM HEPES, 10 mM L-glutamine, 100 U/ml 
penicillin, 100 µg/ml streptomycin, 110 µg/ml sodium pyruvate, 1% non-essential amino 
acids (100 X stock), 4.5 g/L glucose, and 1.5 g/L of NaCO3, each from Sigma (Sigma 
Aldrich, St. Louis MO, USA). Cells were grown and maintained at 37°C with 5% CO2 in 
Corning 75 cm2 culture flasks.  To differentiate THP-1 cells towards a macrophage 




Indirubin derivatives and phorbol-12-myristate-13-acetate were purchased from 
Alexis Biochemical (San Diego, CA), solubilized in DMSO (Sigma Aldrich) to a stock 
solution of 10-2 M and stored at -20° C in sealed vials until ready for use. Stock 
preparations were diluted to a final working concentration using supplemented RPMI 
just prior to use.  The cells were stimulated with 0.1 µM PMA for 48 hours prior to 
treatment in order to induce differentiation. Cells were treated with 0.01% DMSO 
carrier, indirubins alone, 0.1 µg/ml lipopolysaccharide from E. coli, Serotype R515 (Re) 
(ultra pure,TLR4grade™) (Alexis Biochemical, San Diego, CA), or in combination, 
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depending on the experiment using approaches previously described for RAW264.7 
cells.  
 
Comparing the AhR activity of E804 to select indirubin derivatives 
 
THP-1 cells were seeded at 106 cells/ml in 25 cm2 culture flasks (Corning Inc., NY) 
and treated with 0.1 µM PMA for 48 hr for differentiation.  Cells were then treated for 
another 24 hr with 1 µM of multiple available indirubins, as well as PCB-126, a potent 
AhR ligand to be used as a positive treatment for CYP1A1 induction.  Cells were 
prepared for qPCR as described for RAW264.7 cells, but using human CYP1A1 specific 
primers (Table 2).  This screening of indirubins for AhR activity revealed that E804 is a 
weak inducer of CYP1A1, while 7-bromoindirubin-3’-monoxime (7BIO ) is very potent – 
more so than PCB-126 (data not shown).  Additional experiments were conducted to 
determine if 12 hr vs 24, and 0.1 µM vs 1 µM E804 and 7BIO resulted in optimal CYP1A1 
expression.  Considering that 12 hr vs. 24 hr exposuures may lead to different results, IL-
6 expression following 12 hr vs 24 hr exposure to LPS was examined.  As described in the 
results section, 1 µM at 24 hr was optimal for both E804 and 7BIO, and there were no 
differences in IL-6 expression at 12 hr vs 24 hr.  From this point onward, studies to 
further characterize the effects of 1 µM E804 on inflammation profiles also examined 
the effects of 1 µM 7BIO (Figure 2) as a means to evaluate two indirubins varying widely 











Cellular respiration as an indication of viability was measured by the MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay.  Macrophages were 
plated into 96 well Costar plates at 105 cells per well in 100 μl of RPMI media.  After 48 
hr treatment with 0.1 µM PMA, compounds and DMSO carrier control (0.01% final) 
were added in triplicate over serial dilutions of compounds of interest, beginning with 
50 µM per well, and the plates incubated for 24 hr.  Developing the MTT assay and 
quantifying data followed the same procedures as described for RAW264.7 cells.  
 
qRT-PCR for expression of IL-6, IL10, COX-2, iNOS, CYP1A1, TNFα, IL1β, IDO I&II, and ARG 
I&II 
 
THP-1 cells were seeded at 106 cells/ml in 25 cm2 culture flasks (Corning Inc., NY) 
and treated with 0.1 µM PMA for 48 hr.  Cells were then treated for 24 hr with 0.1 
μg/ml LPS, 1 μM E804 or 7BIO, or each indirubin and LPS in combination for 24 hr.  This 
experimental regimen was repeated three times and the adhered macrophages scraped 
from the flask surfaces, then harvested by centrifugation.  qPCR was carried out as 
described for RAW264.7 cells, but using human-specific primers (Table 2).  Genes of 
interest were chosen based on results from RAW264.7 cells, and also to include 
indoleamine diooxygenases I & II, and arginine I & II as markers of possible polarization 
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of macrophages from typical MI (acute inflammatory) to M2 (more low-grade, chronic 




Gene Name Accession #  Primer Sequence (5’    3’)          Tm 
0
C      Product  
                                 size (bp) 
 
GAPDH  NM_001256799.1  F: AGCCTCAAGATCATCAGCAATGCC  57 105 
     R: TGTGGTCATGAGTCCTTCCACGAT  
 
CYP1A1  NM_000499.3  F: GACACAGTCACAACTGCTATCT  53 82 
     R: GCTCCTCTTGGATCTTTCTCTG    
  
IL1-β  NM_000576.2  F: AACAGGCTGCTCTGGGATTCTCTT  57 92 
     R: ATTTCACTGGCGAGCTCAGGTACT    
 
IL-6   NM_000600.3  F: TCAATGAGGAGACTTGCCTGGTGA  58 123 
     R: TACTCATCTGCACAGCTCTGGCTT    
 
TNF-α  NM_000594.2  F: AGGACGAACATCCAACCTTCCCAA  57 92 
     R: TTTGAGCCAGAAGAGGTTGAGGGT    
 
IDO1  NM_002164  F: CACTTTGCTAAAGGCGCTGTTGGA  57 140 
     R: GGTTGCCTTTCCAGCCAGACAAAT    
     
IDO2  NM_194294   F: TGGAAATTGGGAACCTGGAGACCA  57 106 
     R: ATCCCAGGCACTGCTTCTTTCTCT    
     
IL-10  NM_000572  F: TCCTTGCTGGAGGACTTTAAGGGT  57 109 
     R: TGTCTGGGTCTTGGTTCTCAGCTT 
 
iNOS  NM_000625.4  F: GTCAGAGTCACCATCCTCTTT  52 129 
     R: GCAGCTCAGCCTGTACTTATC 
 
COX-2  NM_000963  F: TACTGGAAGCCAAGCACTTT  52 92 
     R: GGACAGCCCTTCACGTTATT 
 
Arginase I  NM_000045.3  F: CAGGGCTACTCTCAGGATTAG  52 115 
     R: CCGAAACAAGCCAAGGTTATT 
 
Arginase II  NM_001172.3  F: CATGGACAGCCAGTTTCATTTC  52 127  
     R: CCACGTCTCTCAGACCAATATAC 
 
Table 2 
qRT-PCR primer sequences targeting human IL-6, IL-10, COX-2, iNOS, CYP1A1, TNF-α, IL1-β, 
IDOI&II, and ARG I&II.
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Immunoblotting for COX-2 and p21 protein expression:  
 
Triplicate experiments were performed in which 1.5 x 106 macrophages were 
seeded in 25 cm2 flasks in 3 ml of RPMI containing 0.1 µM PMA for 48 hr. Cells were 
then treated for 24 hr with 0.1 μg/ml LPS, 1 μM E804 or 7BIO, or each indirubin and LPS 
in combination for 24 hr.  Cells were scraped from each flask and processed for SDS-
PAGE and immunoblotting as described for RAW264.7 cells.  Membranes were then 
probed for 2 h with goat anti-COX-2 antibody (C-20; Santa Cruz Biotechnology) at 1:750, 
mouse anti-p21 (556430; BD Transduction Labs) at 1:500, or anti-mouse β-actin (mAb 
AC- 74; Sigma Chemical Company) at 2 µg per ml. Antibodies were diluted in PBS-tw20  
containing 1% FCS. The blots were washed three times for 10 min with PBS-tw20, and  
probed for 2 h with either rabbit anti-goat IgGm, or goat anti-mouse IgG secondary 
antibody conjugated with alkaline phosphatase (SouthernBiotech) diluted 1:1000 in PBS-
tw20 containing 1% FCS. After extensive washings with PBS-tw20, alkaline phosphatase 
activity was determined using the substrate NBT-BCIP as means to visualize the relative 
amount of specific protein. Band densities for each protein were quantified using 
BioRad G-17 documentation system, and the relative amount of iNOS and COX-2 protein 
expression were normalized to the β-actin loading control. Data were expressed as 




IL-6 and IL-10 secretion:  
 
For IL-6 and IL-10 secretion, THP-1 cells were seeded in 96 well plates at 1x105 
cells per well in supplemented RPMI.  Following a 48 hr treatment with 0.1 µM PMA for 
48 hr for differentiation, cells were treated for 24 hr with 0.1 μg/ml LPS, 1 μM E804 or 
7BIO, or each indirubin and LPS in a total 200 µl.  Interleukin-6 and 10 were quantified 
by human IL-6 and IL-10 ELISA MAX systems (Biolegend) as described for RAW264.7 
cells.   
 
Intracellular lysozyme activity as an indicator of lysozyme protein content: 
  
THP-1 cells were seeded in 96 well plates at 1x105 cells per well in supplemented 
RPMI.  Following a 48 hr treatment with 0.1 µM PMA for 48 hr for differentiation, cells 
were treated for 24 hr with 0.1 μg/ml LPS, 1 μM E804 or 7BIO, or each indirubin and LPS 





THP-1 cells were seeded in 96 well plates at 1x105 cells per well in supplemented 
RPMI.  Following a 48 hr treatment with 0.1 µM PMA for 48 hr for differentiation, cells 
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were treated for 24 hr with 0.1 μg/ml LPS, 1 μM E804 or 7BIO, or each indirubin and LPS 
in a total 200 µl.  Phagocytosis was measured as described for RAW264.7 cells. 
 
III.  Oxidative burst in retinoic acid-differentiated HL-60 cells (neutrophils). 
 
HL-60 cells were obtained from ATCC, and cultured in RPMI-1640 (Cellgro) 
supplemented with 10% heat-inactivated FCS with iron (Atlas; Fort Collins CO), 20 mM 
HEPES, 10 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, 110 µg/ml 
sodium pyruvate, 1% non-essential amino acids (100 X stock), 4.5 g/L glucose, and 1.5 
g/L of NaCO3, each from Sigma (Sigma Aldrich, St. Louis MO, USA). Cells were grown and 
maintained at 37°C with 5% CO2 in Corning 75 cm2 culture flasks.   Retinoic acid was 
purchased from Alfa Aesar, through VWR Scientific, and dissolved to 0.01 M in DMSO, 
then diluted in media prior to use.  Cells were allowed to differentiate in 1 µM retinoic 
acid for 6 days prior to treatment with indirubins and LPS, then washed by 
centrifugation and plated out in black 96-well microtiter plates (Corning, CoStar #3904) 
at 1x105 cells per well in 100 µl media.  Cells were then treated for 24 hr with 0.1 μg/ml 
LPS, 1 μM E804 or 7BIO, or each indirubin and LPS in a total 200 µl.  Some cells were 
treated with the above regimens that also included 25% supernatants from HMC-1 cells 
growing to near confluence in culture medium [Iscove’s modified Dulbecco’s medium 
(IMDM) supplemented with 10% fetal calf serum (FCS), 2mM L glutamine, 100 IU/ml 
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penicillin, 50 mg/ml streptomycin, 2 mM α-thioglycero]).  The experiment was repeated 
three times, and treatments included three wells of each plate. 
 To initiate the oxidative burst assay, H2DCFA at a final concentration of 10 µM 
was added to all wells of the plate and the cells incubated for 15 min, at which time the 
plates were read at excitation/emission wavelengths of 494/522 nM.  PMA at a final 
concentration of 0.2 µM was added to each well, and the plates read again 90 min later.  
The data were recorded, and relative fluorescence units (RFU) converted to stimulation 






E804 at 1 µM and less are not cytotoxic, nor pro-apoptotic and pro-necrosis 
 
Using the MTT assay, which measures succinate dehydrogenase activity (Tim, 
1983), the effects of E804 on cellular respiration in RAW264.7 cells as an indication of 
toxicity were examined over a range of concentrations for 24 h.  One µM and below did 
not affect respiration (Figure 3) and was chosen for further studies.  To confirm that 1 
µM was not only non-cytotoxic, but non-pro-apoptotic and non-pro-necrotic as well, 
annexin-V binding was quantified following treatment with 1 µM of E804, 1 µg/ml LPS, 
or both in combination.  The results of annexin-V labeling reflect MTT assay results in 
that > 99 % of cells are viable, and not apoptotic or necrotic after 24 h exposure to 
treatments (Figure 4). 





Effects of E804 on cellular respiration in RAW264.7 cells, as determined by the MTT assay. 
Data are presented as percentage of control and shown as the mean ± standard error of n = 3 



































Figure 4   
Annexin-V labeling of RAW246.7 macrophages following 24 hr exposure to 1μM E804, 1 µg/ml 
LPS, and E804 + LPS as measured by flow cytometry. Annexin V (FL1-H) and propidium iodide 
(FL3-H) labeling.  (A)  Guide figure of typical results: I- Early apoptosis; II-Late apoptosis;  III-
Viable cells, not undergoing apoptotoic events; IV- Early apoptosis.  Effects of treatment are 
shown in other panels (B) LPS, (C) E804, (D) E804+LPS.
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qRT PCR Arrays: LPS-induced proinflammatory genes and cell cycling are sensitive to 
E804 treatment 
 
A commercially available qPCR array platform designed to screen for stress and 
toxicity was used as a first-line investigation to determine if E804 would modulate LPS-
associated changes in gene expression in macrophages, and to explore possible effects 
of E804 alone.  Data from such arrays are expressed as relative fluorescence units, not 
absolute fold change or mRNA copy number.  These data do, however, provide an 
indication of relative magnitude of expression compared to controls, and with this 
particular array investigators are given a snap shot of genes associated with 
inflammation, apoptosis, cell cycle control, and oxidative stress. 
As expected, LPS-activated macrophages exhibit an increased expression of 
several inflammatory genes available on this particular array (Table 3).  In the case of 
Chemokine ligand 4, MMIF, and NF-κβ, E804 alone increased expression, but inhibited 
expression in combination with LPS.  Otherwise, E804 was either non-effective or was 
inhibitory in terms of expression of genes examined using this approach.  For example, 
cells treated with E804 alone exhibit only a slight increase in iNOS expression.  On the 
other hand, E804 was a potent inhibitor of LPS-induced expression of iNOS, IL-1α, IL-1β, 
and IL-6 genes.  
As part of the screening for stress and toxicity, select genes associated with 
apoptosis and anti-apoptosis were investigated.  Expression of Caspase 1, Caspase 2, 
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and Annexin 5 were elevated by treatment with E804 alone, with similar levels of 
expression observed following LPS treatment alone.   In combination, LPS and E804 
completely shut down expression of these three genes.  Likewise, Bcl2-associated-x and 
Bcl-2-like protein expression levels were strongly suppressed by combined treatment 
with LPS and E804, though treatments with each alone had little effect on expression.  
Two genes directly involved in initiating apoptosis, NF-κβ and TNR receptor 1a, were 
suppressed by E804, which was overcome in the presence of LPS. 
Nine genes associated with cell cycle control and regulation were part of the 
stress & toxicity qPCR array.  Expression of Cyclin C and Cyclin D1 were suppressed by 
E804 treatment, and LPS treatment restored Cyclin D1 expression, but not Cyclin C to 
levels comparable to vehicle-treatments.  LPS treatment was associated with a strong 
expression of EGR-1, which is equally suppressed by E804.  LPS treatment was 
associated with high expression of Mdm2, which is suppressed by E804, and E804 
strongly suppressed expression of p53. 
Genes associated with oxidative stress are also part of the commercial array 
platform, representing Cyp1a1, Fmo4 and Fmo5, and several associated with antioxidant 
responses.  E804 did not induce Cyp1a1 gene expression under the experimental 
conditions described herein.  However, Fmo5, HO-1, and SOD-1 genes were strongly 
increased.  LPS treatment did not change the expression levels of HO-1 in the presence 




Table 3.  Results from commercial qRT-PCR Stress & Toxicity™ arrays targeting select genes associated with inflammation, apoptosis, cell cycle 
control, and oxidative stress.   RAW 264.7 cells were treated with 1 µM E804, 1 µg/ml LPS, E804 + LPS, or 0.01% DMSO as the carrier control for 
24 h.  Cells were harvested and processed for analysis of gene expression using designed commercial qRT-PCR arrays (SuperArray®) following 
instructions provided by the manufacturer.  Data for gene expression represent x-fold changes in mean SYBER-green fluorescence units of 3 
pooled samples compared to carrier control-treated cells, and normalized for house-keeping gene expression.  Details are provided in the 
Methods and Materials section.   
 
Gene Name   Genbank no.  Symbol   E804  LPS  E804 + LPS  
INFLAMMATION 
CSF    NM_009969  Csf2   +2.68  +27.29  -1.64   
Chemokine ligand 10  NM_021274  Cxcl10   -72.64  +3.34  -928.16  
Chemokine ligand 4  NM_013652  Ccl3   +633278 +190362 -38.6 
IL-18    NM_008360  Il18   -1.16  -1.4  -1669.83  
IL-1α    NM_010554  Il1a   +2.68  +169.9  -14.75   
IL-1β    NM_008361  Il1b   -2.29  +35.45  -1.89   
IL-6    NM_031168  Il6   +2.38  +67.89  -1.94   
MMIF    NM_010798  Mif   +4862.56 +350089 -1.39   
NF-Kβ (p105)   NM_008689  nfkb1   +6500  +16920  -1.46   
iNOS    NM_010927  Nos2   +2.36  +10.19  -1.35 
 
  APOPTOSIS   
Caspase 1   NM_009807  Casp1   +446703 +6562  -1.39 
Capspase 8   NM_009812  Casp2   +265.75 +418.16 -1.37 
Annexin 5   NM_009673  Anxa5   +173821 +91288  -1.09 
Bcl2-assoc x   NM_007527  Bax   +3.95  -1.05  -21897 
Bcl2-like protein  NM_009743  Bcl2l1   -302.91  +2.55  -21897.7 
NFkappa B inhib  NM_010907  Nfkbia   -13.53  +2.88  +1.01 





Table 3 (continued) 
 
Gene Name   Genbank no.  Symbol   E804  LPS  E804 + LPS  
 
CELL CYCLE CONTROL AND REGULATION 
Cyclin C    NM_016746  Ccnc   -335.31  -1.21  -1072.65  
Cyclin D1   NM_007631  Ccnd1   -3564  -1.51  +1.02   
Cyclin G1   NM_009831  Ccng1   +7.2  -1.07  -11.9   
E2f tf-1    NM_007891  E2f1   -968.65  -1.18  -3201.7 
EGR-1    NM_007913  Egr1   +2.68  +8989  -1.81  
PCNA    NM_011045  pcna   -5  + 15.98  -1.27   
CDKI-1α (p21)   NM_007669  Cdkn1a   -3.92  -1.06  +1.13  
3T3 c.d.m.2   NM_010786  Mdm2   +2.68  +25458  -1.95 
P53    NM_001640  Trp53   -6387  1.15  -1.35 
 
       OXIDATIVE STRESS 
CYP1A1    NM_009992  cyp1a1   +2.69  +1.01  +1.46 
Flavin moxy 4   NM_144878  fmo4   +2.68  +5.23  -7.58 
Flavin moxy5   NM_010232  fmo5   -54.06  -1.75  -1.21 
Glutathione Px1  NM_008160  GPx1   -32.58  -1.37  -1.48 
Glutathione red   NM_010344  Gsr   +2.25  -1.05  +1.84 
Glutathione trans  NM_010358  GSTm1   -507.0  -1.15  -1.36 
Heme Ox 1   NM_010442  Hmox1   +1582.53 +1.01  +6448.8 
Metallothionein 2  NM_008630  Mt2   -4.96  +1.52  -1.55   
Polym II ppK   NM_023127  Polr2k   +8.9  -1.21  -1.06 
P450 oxidored   NM_008898  Por   +1.81  +1.29  +1.1 
Superoxide dis 1  NM_011434  Sod1   +323782 +66465  -1.49 
Superoxide dis 2  NM_013671  Sod2   -457.67  +2.05  -1.69 
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qRT-PCR follow-up to arrays confirms array results  
 
qRT-PCR was carried out to validate the effects of treatments on IL-6 gene 
expression as a keystone cytokine associated with inflammation and systemic acute 
phase responses.  Also quantified, were expression profiles of COX-2, iNOS, IL-10, and 
CYP1A1.  As expected, LPS was a strong inducer for expression of IL-6, iNOS, IL-10 and 
COX-2 genes (Figure 5).  E804 inhibited LPS-induced IL-6, COX-2, and iNOS expression 
(Figure 5), with the most impact on IL-10 expression, but did not induce CYP1A1 gene 
expression (data not shown), thereby reflecting a rather anemic CYP1A1 response noted 
from the array data.  Previous unpublished work from our lab shows that RAW264.7 
cells are unresponsive to 3’, 3’, 4’, 4’, 5-pentachlorobiphneyl (PCB-126), a potent 
environmental AhR ligand, in terms of CYP1A1 gene expression. 
 
Cellular iNOS and COX-2 protein expression is modestly affected by E804 
 
As expected, LPS is a strong inducer of both iNOS and COX-2 at the protein level 
at both 12 and 24 h of treatment (Figure 6a).  E804 did not induce visible protein, and 
modestly reduced LPS-induced expression (Figure 6b).  When band densities were 
compared for all three replicate experiments, iNOS levels were more dramatically 
suppressed compared to COX-2.  At least at the protein level, COX-2 induction is only 






 Real time quantitative PCR measuring the expression of COX-2, iNOS, IL-6, and IL-10 
in RAW246.7 macrophages. Cells were treated 24 h with carrier control (0.01% DMSO), 1 µM 
E804, 1 µg/ml LPS, or LPS + E804 prior to quantifying gene expression.  Data represent the 
mean ±  standard error of n = 3 independent experiments in which specific gene expression 
was compared to controls and normalized as fold-difference compared to expression of β-








Con      E804      LPS        E + L         Con     E804     LPS      E + L         
12 hour treatment                             24 hour treatment
 
Figure 6 
The effects of carrier control (0.01% DMSO), 1 μM E804, 1 μg/ml LPS, and LPS + E804 on iNOS 
and COX-2 in RAW 264.7 cells following 24 h treatments.  Cell lysates were subjected to SDS-
PAGE and immunoblotting.  A.  Representative immunoblots showing iNOS, COX-2, and β-
actin as a loading control at 12 and 24 h treatment.  B. Data represent the mean band 




Cellular lysozyme and iNOS enzymatic activity are reduced by E804 in the presence of LPS 
 
 Macrophages are a key source of iNOS and antimicrobial proteins, and both iNOS 
and lysozyme enzymatic activity are easily quantified using standard procedures.  At 
least under these experimental conditions, lysozyme activity is not enhanced by 
treatment with LPS (Figure 7), nor is it modulated by E804 when give alone.  However, 
E804 in combination with LPS suppressed lysozyme enzymatic activity by nearly 30%.  
iNOS activity (NO secretion into media) is highly induced by LPS, and E804 strongly 
inhibits the production of NO. 
 
LPS-induced Interleukin-6 and IL-10 secretion are suppressed by E804 
 
As demonstrated in the study described herein, LPS is predictably a potent 
inducer of IL-6 and IL-10 secretion in RAW264.7 macrophages (Figure 8).  Under the 
present experimental conditions, E804 had no effect on basal IL-6 and IL-10 secretion, 
but suppressed secretion stimulated by LPS.  IL-10 secretion was more dramatically 







 The effects of carrier control (0.01% DMSO), 1 μM E804, 1 μg/ml LPS, and LPS  + E804 on 
cellular lysozyme and iNOS enzymatic activity in RAW 264.7 cells following 24 h treatments. 
 Cell lysates were used as the source of lysozyme and cell supernatants were used as a source 
of nitric oxide.  Data represent the mean enzymatic activity (NO production or lytic units) ± 





 Figure 8 
The effects of carrier control (0.01% DMSO), 1 µM E804, 1 µg/ml LPS, and LPS + E804 on the 
secretion of IL-6 and IL-10 by RAW 264.7 following 24 h treatments.  Supernatants were 
removed and IL-6 and IL-10 quantified in supernatants by ELISA.  Data represent the mean ± 
standard error of n = 3 independent experiments.  * represents significance (P ≤ 0.05).
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Phagocytosis and intracellular killing are sensitive to E804 treatment 
 
 Gene expression, cytokine secretion, and lysozyme activity data from this study 
demonstrate that E804 is a potent indirubin derivative with significant potential in 
suppressing macrophage responses to LPS.  To further characterize macrophage 
functions, we determined the effects of E804, LPS, and both in combination on two very 
important endpoints; phagocytosis and intracellular killing (Figure 9).  Compared to 
treatment with the vehicle control, E804 suppressed the ability of macrophages to 
phagocytize latex beads.  Phagocytosis was not enhanced by treatment with LPS, but 
was suppressed by E804 in combination with LPS. 
 Intracellular killing of E. coli was determined by quantifying survival of bacteria 
survival following the 3 h co-incubation with macrophages, and was not affected by pre-
treatment with LPS.  Indirubin E804 treatment alone enhanced bacterial survival, and 
thus indicating that macrophages were less able to kill intracellular bacteria as a direct 
result of treatment.  Though LPS alone did not affect intracellular killing compared to 
the vehicle-control, LPS treatment seems to protect macrophages from E804-related 






The effects of carrier control (0.01% DMSO), 1 μM E804, 1 μg/ml LPS, and LPS 
+ E804 on phagocytosis of fluorescent beads and intracellular killing of E. coli by RAW 
264.7 cells following 24 h treatments.  Data are presented as percentage of control, and 
shown as the mean ± standard error of n = 3 independent experiments. * represents 
 significance (P < 0.05).
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THP-1 Macrophage Model 
 
Time vs. concentration comparison for CYP1A1 and IL-6 expression 
 
Considering that the two indirubins with very different abilities to induce CYP1A1 
(from preliminary studies) may have very different effects on inflammatory profiles, and 
especially in combination with LPS as the initiator of inflammatory responses, additional 
preliminary studies were carried out to determine an optimal (12 hr vs 24 hr), and if 
there may be a better response to a lower level of indirubin.  There were no differences 
in E804-induced CYP1A1 expression between 12 and 24 hr treatment at 0.1 µM, but at 1 
µM concentration the expression was greater at 24 hr (Figure 10A).  Compared to 7BIO, 
E804 is a relatively weak inducer of CYP1A1.  CYP1A1 expression at 1 µM concentration 
following 24 hr treatment with 7BIO was much higher than the other three 
combinations (Figure 10B).  No differences were seen in LPS-induced expression IL-6 




















































































IL6 expression with LPS treatment





















































Real time quantitative PCR measuring the expression of CYP1A1 and IL-6 at 0.1 µM and 1 µM 
indirubins at 12 and 24 h.  THP-1 macrophages were stimulated with 0.1 µM PMA for 48 hours 
and then treated with carrier control (0.01% DMSO), 0.1 µg/ml LPS , indirubins alone, or 
indirubins + LPS  for 12 or 24 h prior to quantifying gene expression.  Data represent the mean 
±  standard error of n = 3 independent experiments in which specific gene expression was 
compared to controls and normalized as fold-difference compared to expression of β-actin as 
a housekeeping gene. * represents significance (P ≤ 0.05), *** (P ≤ 0.001).
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Effects of E804 and 7BIO on cell viability 
 
The MTT assay was used to study the effects of E804 and 7BIO of cellular 
respiration in THP-1 human monocytes. This assay measures succinate dehydrogenase 
activity (Tim, 1983) as an indication of toxicity over a range of concentrations for 24 h.  
One µM and below of E804 and 7BIO did not affect viability (Figure 11).  The effect on 
cellular respiration was then measured following treatment with carrier control (0.01% 
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Effects of E804 and 7BIO on cellular respiration in THP-1 cells as determined by the MTT assay. 
THP-1 macrophages were stimulated with 0.1 µM PMA for 48 hours and then treated with 
concentrations of E804 and 7BIO from 32
 
µM to 1 µM for 24 hr.  Tributyltin chloride (TBT) at a 
concentration of 10 µM was included as a positive control showing cytotoxicity. Data are 
presented as percentage of control, and shown as the mean ± standard error of n = 3 








Effects of treatment on cellular respiration in THP-1 cells as determined by the MTT assay. 
THP-1 macrophages were stimulated with 0.1 µM PMA for 48 hours and then treated with 
carrier control (0.01% DMSO), 0.1 µg/ml LPS , 1 µM indirubins alone, or indirubins + LPS  for 24 
h.  Data are presented as percentage of control, and shown as the mean ± standard error of n 
= 3 independent experiments. 
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qRT-PCR--IL-6, IL10, COX-2, iNOS, CYP1A1, TNFα, IL1β, IDOI&II, and ARG I&II 
 
qRT-PCR was carried out to determine the effects of E804 and 7BIO on IL-6 
expression as a key cytokine associated with inflammation and systemic acute phase 
responses.  Also quantified, were expression profiles of COX-2, iNOS, IL-1β, TNF-α, and 
IL-10 for their involvement in the inflammatory response to LPS.  CYP1A1 expression 
was also quantified as a means to determine if LPS treatments, alone and in 
combination with indirubins, affected this sentinel gene for AhR activity.  Moreover, 
because macrophages can be functionally heterogeneous before stimulation and may 
be polarized to either a classical M1 or alternative M2 response, this study also 
quantified the expression of LPS-induced IDO-1, IDO-2, Arg-1, and Arg-2:  gene products 
expressed by M2 macrophages.   
LPS was a potent inducer for the expression of IL-6, IL1-β, and TNF-α genes 
(Figure 13), but not IL-10.  With respect to LPS treatment, E804, but not 7BIO 
suppressed IL-6 expression.  Unlike in RAW264.7 cells, LPS did not stimulate IL-10 
secretion in THP-1 cells, yet both indirubins, alone and in combination with LPS 
stimulated secretion. Like IL-6, TNF-α is a hallmark proinflammatory cytokine secreted in 
response to LPS, and under these experimental conditions, E804 suppressed expression, 
while in combination with LPS 7BIO enhanced production.  Interleukin-1β expression in 
response to LPS was not  altered.  In humans, macrophages do not easily express iNOS, 
even in response to LPS.  However, both indirubins suppress baseline iNOS expression 
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levels (Figure 14A).  LPS only modestly induced COX-2 under these experimental 
conditions, but the combination of 7BIO and LPS was a potent inducer, just as was 
observed for TNFα secretion (Figure 14B).  IDO1 is generally expressed in response to 
LPS, and in this case E804 and not 7BIO suppressed expression (Figure 15A).  IDO2 was 
not significantly altered by any of the treatments (Figure 15B).  Arginase expression is 
generally considered a biomarker for M2 polarized macrophages, and thus would 
indicate that differentiated THP-1 cells are not pro-inflammatory.  However, neither of 
the two arginases responded to LPS, suggesting that these cells are pre-programed 
towards an M1 lineage.  E804, but not 7BIO suppresses baseline arginase-1 expression 
(Figure 15 C,D).  
CYP1A1 is a hallmark gene associated with AhR activation.  In this study using 
differentiated THP-1 cells, E804 only modestly induced CYP1A1 expression, while 7BIO 
and 7BIO + LPS increased CYP1A1 expression with respect to the control (Figure 16).  Of 















































































































































































































































Real time quantitative PCR measuring the expression of IL-1β, TNF-α, IL-6 and IL-10 in THP-1 
cells.  THP-1 macrophages were stimulated with 0.1 µM PMA for 48 hours and then treated 
with carrier control (0.01% DMSO), 0.1 µg/ml LPS , 1 µM indirubins alone, or indirubins + LPS  
for 24 h prior to quantifying gene expression.  Data represent the mean ±  standard error of n 
= 3 independent experiments in which specific gene expression was compared to controls and 
normalized as fold-difference compared to expression of β-actin as a housekeeping gene. * 






























































































































Real time quantitative PCR measuring the expression of iNOS and COX-2 in THP-1 cells.  THP-1 
macrophages were stimulated with 0.1 µM PMA for 48 hours and then treated with carrier 
control (0.01% DMSO), 0.1 µg/ml LPS , 1 µM indirubins alone, or indirubins + LPS  for 24 h 
prior to quantifying gene expression.  Data represent the mean ±  standard error of n = 3 
independent experiments in which specific gene expression was compared to controls and 
normalized as fold-difference compared to expression of β-actin as a housekeeping gene. * 














































































































































































































































Real time quantitative PCR measuring the expression of IDO 1 and 2, and Arginase 1 and 2 in 
THP-1 cells.  THP-1 macrophages were stimulated with 0.1 µM PMA for 48 hours and then 
treated with carrier control (0.01% DMSO), 1 µM 0.1 µg/ml LPS , indirubins alone, or 
indirubins + LPS  for 24 h prior to quantifying gene expression.  Data represent the mean ± 
 standard error of n = 3 independent experiments in which specific gene expression was 
compared to controls and normalized as fold-difference compared to expression of β-actin as 

































































Real time quantitative PCR measuring the expression of CYP1A1 in THP-1 cells.  THP-1 
macrophages were stimulated with 0.1 µM PMA for 48 hours and then treated with carrier 
control (0.01% DMSO), 0.1 µg/ml LPS , 1 µM indirubins alone, or indirubins + LPS  for 24 h 
prior to quantifying gene expression.  Data represent the mean ±  standard error of n = 3 
independent experiments in which specific gene expression was compared to controls and 
normalized as fold-difference compared to expression of β-actin as a housekeeping gene. * 
represents significance (P ≤ 0.05), *** (P ≤ 0.001).
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Cellular p21 and COX-2 protein expression  
 
As expected, LPS induces COX-2 in THP-1 macrophages (Figure 17B).  An increase 
in COX-2 gene expression was seen in 7BIO+LPS compared to both LPS and 7BIO alone. 
No difference in p21 expression was seen in any of the treatment groups. 
 
LPS-induced Interleukin-6 and IL-10 secretion are suppressed by E804 
 
While LPS is a potent inducer of both IL-6 and IL-10 secretion (Figure 18), neither 
E804 or 7BIO alone had an effect on secretion. When the compounds were treated 
together with LPS, IL-6 secretion significantly decreased compared to LPS-treatment, 
though this was not seen in IL-10.  Gene and protein expression seem to be quite 
different in LPS-treated differentiated THP-1 macrophages, which may reflect the point 













 The effects of carrier control (0.01% DMSO), 0.1 µg/ml LPS, 1 µM indirubins alone, or 
indirubins + LPS on COX-2 and p21in THP-1 cells following 0.1 µM PMA stimulation for 48 
hours and 24 h treatments. Cell lysates were subjected to SDS-PAGE and immunoblotting.  A. 
 Representative immunoblots showing COX-2and p21, with β-actin as a loading control at 24 h 
treatment.  B. Data represent the mean band densities ± standard error of n = 3 independent 



























































































 The effects of treatments on the secretion of IL-6 and IL-10 by THP-1 cells. Cells were 
stimulated with 0.1 µM PMA for 48 hours and then treated with either carrier control (0.01% 
DMSO), 0.1 µg/ml LPS, 1 µM indirubins alone, or indirubins + LPS for 24 h.  Supernatants were 
removed and IL-6 and IL-10 quantified in supernatants by ELISA.  Data represent the mean ± 
standard error of n = 3 independent experiments.  **** represents significance (P ≤ 0.0001).
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Cellular lysozyme enzymatic activity  
 
Lysozyme enzymatic activity was increased by LPS, but not by other treatments 
(Figure 19).   
 
Phagocytosis is not sensitive to treatment 
 
To determine if functional macrophage activity was affected by treatments, 
phagocytosis of fluorescent latex beads was measured.  This particular function was not 









































The effects of treatments on cellular lysozyme activity by THP-1 cells. Cells were stimulated 
with 0.1 µM PMA for 48 hours and then treated with either carrier control (0.01% DMSO), 0.1 
µg/ml LPS, 1 µM indirubins alone, or indirubins + LPS for 24 h.  Cell lysates were used as the 
source of lysozyme.  Data represent the mean enzymatic activity (lytic units) ± standard error 











































The effects of treatments on phagocytosis of fluorescent beads by THP-1 cells. Cells were 
stimulated with 0.1 µM PMA for 48 hours and then treated with either carrier control (0.01% 
DMSO), 0.1 µg/ml LPS, 1 µM indirubins alone, or indirubins + LPS for 24 h.  Data are presented 






Phagocyte Oxidative Burst Activity 
 
Under the conditions of experimental conditions described herein, retinoic acid-
differentiated HL-60 cells exhibit the typical polymorphonuclear (PMN) phenotype 
associated with neutrophils.  Upon stimulation with PMA and using the probe H2DCFA, 
these cells reach maximum oxidative burst activity at 90 min, and this effect is 
somewhat enhanced by LPS and by exposure to cytokine containing supernatants 
(Figure 21).  While neither of the treatments affected oxidative burst activity, this 
endpoint was different between E804- and E804 + LPS-treated cells.  There were no 
differences between E804 and 7BIO in terms of affecting oxidative burst activity.  
Despite preliminary data showing that primed neutrophils have higher oxidative burst 


















































































The effects of treatments on PMA-stimulated oxidative burst by HL-60 cells. Cells were 
differentiated with 1 µM retinoic acid for 6 days  and then treated with either carrier control 
(0.01% DMSO), 0.1 µg/ml LPS, 1 µM indirubins alone, or indirubins + LPS for 24 h.  H2DCFA 
was used to detect hydrogen peroxide intermediates. Data represent the mean ± standard 
error of n = 3 independent experiments in which relative fluorescent units (RFU) converted to 
stimulation indices as a ratio of PMA-stimulated RFU to un-stimulated RFU.  * represents 





To our knowledge, this is the first study to examine the effects of E804 on 
RAW264.7 macrophage responses to LPS, and we find that E804 is a potent modulator 
of inflammation-related physiological endpoints.  While others have examined the anti-
cancer and anti-inflammatory effects of E804 on various cell lines (Nam et al., 2005; 
Nam et al., 2012), those studies used 5 – 10 µM levels, or higher, we found that 
concentrations above 1 - 2 µM were cytotoxic.  In our study, 1 µM was more suitable for 
determining immunopharmacological effects, and in line with previous work (Springs 
and Rice, 2006) using U937 human histiocyte/monocytes to determine the effects of 
indirubin-3’-monoxime at the same concentration on gene expression during activation 
and differentiation.  
Treating macrophages with LPS is a common model for understanding basic 
physiological responses to gram negative bacteria, and especially those responses 
mediated through TLR4.  In an effort to determine the likelihood of cell stress and 
toxicity resulting from E804 on the model, a targeted qRT-PCR array of select genes was 
employed, and highlights are as follows.  Those genes associated with inflammatory 
responses to LPS were suppressed by E804.  As previously demonstrated by others 
(Knockaert et al., 2004; Polychronopoulos et al., 2004), indirubins typically inhibit cell 
cycling control points and dependent kinases, and in this study E804 modulated the 
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expression of those genes.  Oxidative stress genes SOD-1 and HO-1 were the two most 
affected by E804, and indicate perhaps an induction of anti-oxidative stress responses. 
The observation that E804 suppresses LPS-induced iNOS and IL-6, and COX-2 
gene expression in macrophages implies a common mechanism of action.  TLR4 
signaling pathways in macrophages leads to NF-κβ signaling as the primary transcription 
factor for driving the expression of iNOS, IL-6, and COX-2 in macrophages.  In this study, 
iNOS, IL-6, and COX-2 expression at the gene level were sensitive to E804, but at the 
protein level this effect was less dramatic.  However, macrophages treated with LPS also 
secrete IL-10, a Th2 cytokine, that suppresses inflammatory cytokines through STAT3 
signaling (Chanteux et al., 2007).  Rather than through TLR4 and NF-κβ pathways that 
drive the expression of proinflammatory cytokines, IL-10 expression in response to LPS 
is mediated through TLR4/MAPKinases and Sp-1-dependent signaling (Chanteux et al., 
2007).  Under physiological conditions, IL-10 expression by macrophages may be a 
means to self-limit aggressive inflammatory responses to stimulants like LPS, as well as 
to limit Th1 responses in general.  In this study, E804 suppressed not only 
proinflammatory IL-6, iNOS, and COX-2, but IL-10 expression as well, at both the gene 
and protein level.  A key observation was that the suppressive effect of E804 on IL-10 
expression was greater than the effects on IL-6 and COX-2.  These effects are not unique 
to E804, as indole-3-carbinol, the active indole ingredient in cruciferous vegetables, also 
inhibits both IL-6 and IL-10 in RAW264.7 macrophages (Tsai et al., 2010), and SR31747A 
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(sigma ligand) inhibits both iNOS and IL-10 in the same cell line (Gannon et al., 2001).  A 
unifying mechanism of action for these compounds is not known. 
In terms of mechanisms of action associated with E804, it is difficult to reconcile 
how E804 can inhibit both NF-κβ- and MAPKinase-associated signaling.  However, most 
indirubins inhibit kinases, including cyclin-dependent kinases by blocking the ATP-
binding pocket (Knockaert et al., 2004; Polychronopoulos et al., 2004), therefore one 
possible mechanism of action is that E804 inhibits both the IKKinase associated with NF-
κβ activation and the kinases involved with MAPkinases, thus impacting both pathways, 
leading to suppression of both pro- and anti-inflammatory cytokine production in 
response to LPS.   
Our finding that E804 suppresses both IL-6 gene expression and protein 
secretion is significant because this cytokine is a key player in systemic inflammatory 
processes.  Interleukin-6 is produced by several cell types, including keratinocytes, 
adipocytes, smooth muscle cells, and macrophages, and is considered a potent inducer 
of the systemic acute phase response to infection, tissue damage, obesity, 
atherosclerosis, and variety of stimuli (Krueger et al., 1990; Sugawara et al., 2001; 
Jensen et al., 2003; Cancello and Clement, 2006).  IL-6 is also a growth factor for 
multiple myeloma, prostate, and basal cell carcinoma (Jensen et al., 2003).  It is not 
surprising, therefore, to appreciate the need and effort to find potent, yet safe means to 
modulate the production and activity of IL-6. 
86 
 
LPS-induced iNOS gene and protein expression, and NO production were 
suppressed by E804 treatment under the experimental conditions described herein.  
Inducible nitric oxide synthase (iNOS) is a potent inflammatory mediator and is strongly 
induced by LPS in macrophages (Moncada et al., 1991; Marques et al., 2008), but is also 
expressed in parenchymal cells of liver, colon, and muscle during systemic infection 
(HICKEY et al., 2002).  Moreover, while IL-6 production by macrophages may have 
systemic effects, direct NO production is a local response with local implications.  
Ultimately, nitric oxide (NO) produced by iNOS enzymatic activity contributes to 
oxidative stress, especially when combined with superoxide anion to yield peroxynitrite, 
a potent long lived free radical.  The mechanism of iNOS inhibition by E804 is most likely 
related to its effects on NF-κβ signaling because this transcription factor is a key 
regulator of TLR-4 signaling, affecting not only iNOS activity, but IL-6, COX-2, TNF-α, IL-
1β, and IL-12 as well.  Modest induction of iNOS gene expression in cells treated with 
E804 alone may be related to a similar modest increase in NF-κβ gene expression noted 
in the array.  Thus, iNOS activity is good biomarker for the effects of LPS on 
proinflammatory functions in macrophages and a reliable endpoint for screening 
potential anti-inflammatory compounds.   
 Oxidative stress is an important component of the biology of inflammation 
(Fernández-Sánchez et al., 2011), and several key genes relative to oxidative stress are 
part of the commercial array used in this study.  Oxidative stress under normal 
conditions is controlled by redox cycling of glutathione, which under normal conditions 
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is replenished with functioning glutathione reductases, peroxidases, and transferases.   
Hemoxygenase-1 (HO-1) gene expression stood out as a significant effect of E804 
treatment, even in the absence of LPS.  Since HO-1 is inducible by LPS, inflammatory 
cytokines, and hypoxia this may be an adaptive response in tissue injury, vasculature 
inflammation, and transplantation rejection models (Kapturczak et al., 2004).  At least 
under the conditions of this study, LPS alone did not induce HO-1 expression, and may 
be an intrinsic characteristic of the cell line.  Under physiological conditions, induction of 
HO-1 leads to down regulation of Th1-affiliated (proinflammatory) responses and 
promotes Th2 responses (Sheikh et al., 2011), and is protective against further oxidative 
stress through the formation of billiverdin, which is a reactive oxygen species scavenger 
(Naito et al., 2004).  Induction of HO-1 by E804, and especially the maintenance of HO-1 
induction in the presence of LPS may be an important mechanism of feed-back control 
of aggressive inflammatory actions for this compound since carbon monoxide 
production through bilirubin production inhibits pro-inflammatory cytokine production.  
Though SOD-1 was induced by E804 or LPS alone, any benefit of induction appears to be 
lost or suppressed during co-treatments.  However, it is possible that the reduction of 
HO-1 expression in cells treated with both E804 and LPS is a function of time. 
Lysozyme is an antimicrobial peptide produced in abundance by myeloid cells, 
and secreted into body fluids and cell cultures as part of the innate antimicrobial 
response (Yehuda et al., 2003).  Lysozyme is easily quantified in serum/plasma and 
tears, and can be quantified in cell lysates.  At least under the conditions explored in this 
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study, E804 decreased enzymatic activity, and presumably total lysozyme protein 
content, in the presence of LPS.  The mechanism(s) associated with reduced lysozyme 
content of cells in these experiments are unknown, but the potent immunosuppressive 
glucocorticoid dexamethasone inhibits the secretion of lysozyme in monocytes (Yehuda 
et al., 2003), and the mechanism is probably through inhibition of NF-κβ activation and 
signaling (Crinelli et al., 2000).  Yet the negative endocrine and metabolic side effects 
make potent steroids an unappealing option for routine treatment of inflammation.  In 
this study, E804 suppressed NF-κβ only when treated together with LPS (Table 3), and 
the same is true for lysozyme activity.  Thus, E804 may be a more appealing anti-
inflammatory agent in comparison to steroid use. 
Gene and protein expression, and enzymatic activity profiles in this study 
demonstrate potent effects of E804 on macrophage responses to LPS, but the ability to 
phagocytize particles and kill intracellular bacteria are indicative of cell functions.  One 
of the more interesting observations from these phagocytosis and intracellular killing 
assays was the lack of effect by LPS treatment alone, which generally enhances 
expression of genes and proteins associated with inflammatory-like responses.  A similar 
lack of response to LPS in macrophages has been reported for pinocytosis 
(Peppelenbosch et al., 1999).  To significantly enhance phagocytosis of beads and 
intracellular killing of E. coli, macrophages may require an additional signals such as IFN-
γ or one provided by phorbol esters as a pharmacological stimulant (Vincenti et al., 
1992; Gordon et al., 2005).  But, regardless of the effects of LPS on phagocytosis, E804 
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suppresses the phagocytic ability of RAW264.7 cells, and this is likely due to modulation 
of GSK-3β pathways, which are involved in cytoskeletal changes during engulfment 
(Cabello et al., 2010), and a key target of many indirubins (Meijer et al., 2003; Knockaert 
et al., 2004). 
  This study also demonstrated that E804-treated cells were compromised in their 
ability to kill intracellular E. coli, but not in cells also treated with LPS.   Considering the 
induction of typical genes and proteins associated with LPS treatment, one would 
predict that cells treated with LPS would be more efficient at clearing intracellular 
bacteria.  However, considering the above discussed similarity in effects on phagocytosis 
of beads, macrophages may require additional signals such as IFN-γ or pharmacological 
stimulation in addition to LPS for more efficient intracellular killing of bacteria.  While 
we did not include IFN-γ or phorbol esters in this particular study, this may be a key 




In this study, PMA-differentiated THP-1 cells towards a macrophage lineage was 
used to further test the effects of indirubin E804 on pro-inflammatory responses to LPS, 
but using a cell line model responsive to AhR activation.  Indirubin 7BIO is very potent in 
inducing CYP1A1 gene expression, and from the preliminary screening of indirubins, 
even more so than PCB-126, a model environmental contaminant used to elicit toxicities 
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mediated primarily through AhR signaling (Rice and Schlenk, 1995; Chen, 2010; Zhang et 
al., 2012).  In comparison, E804 has very low AhR activity as evidenced by low 
expression of CYP1A1 (Hu et al., 2007a), an observation that supports findings from the 
RAW264.7 study (this dissertation) that despite very weak AhR activity, or lack thereof, 
E804 holds promise as an anti-inflammatory indirubin, and may be safe compared to 
indirubins with high activity.  It is well known that compounds with high AhR activity are 
associated with toxicities, including immune dysfunction, reproductive and 
developmental abnormalities, and tumorogenesis (Denison et al., 2002b; Denison et al., 
2011; Jönsson et al., 2012). 
As with RAW264.7 cells, differentiated THP-1 cells response well to LPS in that 
key signature genes associated exposure to TLR-4 ligand (LPS), such as IL-1β, TNF-α, and 
IL-6 are induced.  In both cell lines, E804 suppresses LPS-induced IL-6, yet IL-10 
expression profiles are very different in the two lines; gene expression is greatly induced 
in RAW264.7 cells, but not THP-1, though the cytokine is readily secreted by both cells.  
Of note, E804 suppression of IL-10 is seen only in RAW264.7 cells in response to LPS.  
This difference is difficult to fully reconcile, but may be due to the level of 
differentiation of RAW264.cells, which are very similar to primary macrophages, while 
THP-1 cells must be treated with PMA to induce differentiation, and even then are 
referred to as “macrophage like”.  Furthermore, macrophages secrete IL-10 as a means 
to self-regulate activation, and the time from gene expression to secretion of the 
protein may be different between these two cell lines at the time of use (no PMA 
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stimulation for the mouse macrophage, PMA-stimulation for the human cell line).  PMA 
is a diacylglycerol mimic, and as such can stimulate PKCδ activity, and the long term 
effects of this treatment to induce differentiation may be revealed in altered cytokine 
secretion.  With regards to systemic inflammation, IL-6 is a key initiation of the acute 
phase response, and at least in the in vitro models used herein, E804 and 7BIO suppress 
LPS-stimulated secretion, thus indicating anti-inflammatory properties. 
While COX-2 expression in RAW264.7 cells is highly responsive to LPS, 
differentiated THP-1 cells are less responsive, in terms of fold-increase in expression.  At 
least in differentiated THP-1 cells, COX-2 expression is increased by 7BIO + LPS, 
suggesting that whatever the mechanism is associated with a relatively small increase in 
expression (compared to RAW264.7 cells) is alleviated by 7BIO.  Strong Ahr ligands, such 
as PCB-126 and especially TCDD, are known to induce COX-2, and probably through two 
different mechanisms.  First, the COX-2 gene has an AhR response element (Vogel et al., 
2007), but equally important is the activation of c-src signaling in the cytosol associated 
with PLA2 activation and arachidonic acid metabolism to COX-2 (Vogel et al., 2003), as 
well as non-canonical pathway to NF-κβ activation through RelB, and the canonical 
pathway of RelA. 
One of the enigmas of human immunology is the near lack of iNOS activity in 
response to LPS so typically found in rodent models.  iNOS is easily induced by TNF-α 
and IL-1β, but slow to react to LPS, and this may be due to feedback regulation in 
sensing NO by humans.  Nitric oxide is quickly oxidized to nitrate in humans, therefore 
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nitric oxide reductase enzymes are required for simple assays like the Griess assay used 
in mouse cell lines (Marzinzig et al., 1997).  At least in differentiated THP-1 cells, LPS did 
not stimulate the expression of iNOS, but both indirubins further suppressed expression.  
This may indicated that iNOS expression in humans is not as tightly linked to RelA (p65) 
signaling and NF-κβ activation as it is in rodents (Karin et al., 2004; Miller et al., 2010).  
Markers of possible polarization of differentiated THP-1 cells from M1 (classical 
inflammatory) to alternatively activated (low grade, chronically activated) M2 cells were 
examined.  Of the four genes examined, IDO-1, IDO-2, Arginase-1, and Arginase-2, only 
IDO-1 was induced by LPS, and this was reduced by E804, but not 7BIO.  If all four genes 
were altered by treatments, this would indicate a switch from producing iNOS, as an 
example, from L-arginine metabolism to L-citrullene for producing nitric oxide, towards 
L-arginine metabolism to urea and L-ornithine.  Urea and ornithine are classical products 
of activated M2 macrophages (Mantovani et al., 2013).  Taken as a group of indicator 
genes, at least under the conditions of this study, differentiated THP-1 cells display an 
M1 phenotype, and serve as a good model for classical inflammatory processes.  
To minimally address the question of genotypic vs phenotypic changes in 
differentiated THP-1 cells, cytosolic lysozyme activity and cellular phagocytosis were 
examined.  Only LPS increased lysozyme activity, and presumably this is due to an 
increased expression of the protein, not increased activity of the enzyme.  The lack of 
effect on lysozyme activity by either indirubin strongly suggests that pathways leading 
to increased expression (cellular content) are not targets.  The same is true for 
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phagocytosis, in that the rate of uptake of beads was not affected by treatments.  
Phagocytosis involves a complicated interaction of membrane fusion and cytoskeleton 
contraction, yet neither of these seemed to be affected.  It may be that E804 and/or 
7BIO affect only “inducible” systems.  In terms of inducibility, most strong AhR ligands 
not only induced CYP1A1 as a marker of exposure, but downstream gene products 
involved in cell cycle maintenance (Knockaert et al., 2004), one of which is p21.  At least 
in this study, even the strong AhR ligand 7BIO did not alter expression of p21, which this 
may be due to rapid metabolism of most indigoids (Guengerich et al., 2004) and the 
time frame of this study may have missed any possible changes in expression. 
 
Retinoic-acid differentiated HL-60 cells/neutrophils and oxidative burst activity 
 
Oxidative burst activity in phagocytes is one of the most critical aspects of innate 
immunity in that any deficiency in the NADPH oxidase system will inhibit the ability of 
the cell to produce reactive oxygen species, namely superoxide anion, and is the 
underlying pathology associated with chronic granulomatous disease (CGD).  In CGD, 
there is a loss or mutation on the X-chromosome coding for p91PHOX, and patients are 
overwhelmed with bacterial and fungal infections normally impeded by a functioning 
phagocyte (Cross et al., 2000; Heyworth et al., 2001).  In the study described herein (this 
dissertation), HL-60 cells were differentiated to a neutrophil phenotype by retinoic acid 
over a 6 day period.  Cells under these conditions respond well to PMA in terms of 
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initiation of NAPH oxidase activity, with stimulation indices typically 4-5 and beyond 
over un-stimulated cells.  Only cells treated with both E804 and LPS were significantly 
altered compared to indirubin alone in how they responded to PMA, and the biological 
significance of this observation may be only in that E804 may synergize with LPS in 
terms of altering the membrane containing parts of the NADPH oxidase complex at the 
time of stimulation.   
Not examined in this particular study was the possible effect of treatment on the 
ability of these cells to respond to increases in intracellular calcium.  Normally, the 
oxidative burst response occurs during contact with a pathogen, such as during 
phagocytosis, and this contact initiates PLCδ activity to in turn release DAG that 
activates PKC to directly phosphorylate p67PHOX and p47PHOX.  Elevated intracellular 
calcium results from IP3 release during PLCδ activity, and this in turn activates PLA2 to 
release arachidonate that leads to the translocation of p47PHOX to the membrane 
(Babior, 1999; Babior et al., 2002).  Pharmacologically, DAG can be mimicked with PMA, 
while IP3 can be mimicked with calcium ionophores, each given alone, or both in 
combination to give the strongest signal (Rice and Weeks, 1989; Rice and Weeks, 1991).  
Future studies examining oxidative burst activity and indirubins E804 and 7BIO should 







Conclusion:   
This study suggests that indirubin E804 is a novel and promising 
immunomodulating compound with potent negative effects on iNOS, IL-6, and COX-2 
expression, while also suppressing IL-10 expression and enhancing HO-1 expression.  
Induced expression of HO-1 may promote antioxidant responses as a means to control 
inflammatory responses.  Three key future studies with E804 related directly to immune 
responses are needed;  1. Determine the effects of E804 on phagocyte responses to 
opsonized and non-opsonized intracellular pathogens, and 2.  Determine the in vivo 
effects of E804 on a battery of other immune responses, and 3.  To determine the 
therapeutic potential of this anti-inflammatory agent for protection against endotoxin-
induced animal lethality.  In addition, if the findings that E804 is not an AhR ligand are 
consistent throughout additional studies using multiple models, then this particular 
immunomodulating indirubin derivative may be a safe clinical alternative to strong 
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